Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 14/20 | 0.66 |
| ▸ | PPARA | Q07869 | 14/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30875863 | 1.00 | PPARG (0.66) | PPARGPPARASMN1; SMN2FFAR1KDM4E | |
| SCHEMBL14121845 | 0.87 | SMN1; SMN2 (0.74) | PPARGPPARASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL16571461 | 0.87 | SMN1; SMN2 (0.74) | PPARGPPARASMN1; SMN2 | |
| SCHEMBL16566851 | 0.86 | SMN1; SMN2 (0.59) | PPARGPPARASMN1; SMN2KDM4ELMNA | |
| SCHEMBL11753889 | 0.85 | SMN1; SMN2 (0.57) | PPARGPPARASMN1; SMN2 | |
| SCHEMBL1566516 | 0.84 | PPARG (0.59) | PPARGPPARASMN1; SMN2 | |
| SCHEMBL1564883 | 0.84 | PPARG (0.62) | PPARGPPARASMN1; SMN2FFAR1KDM4E | |
| SCHEMBL28285419 | 0.84 | AR (0.53) | PPARGPPARASMN1; SMN2FFAR1KDM4E | |
| SCHEMBL14241612 | 0.83 | SMN1; SMN2 (0.56) | PPARGPPARASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL14121533 | 0.83 | SMN1; SMN2 (0.56) | PPARGPPARASMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765639-B2 | Alkoxylated asymmetric alkylamine surfactants as adjuvants | AKZO NOBEL N.V. (NL) | 2014-07-01 | — | — | US | claimed |
| EP-2161992-B1 | ALKOXYLATED ASYMMETRIC ALKYLAMINE SURFACTANTS AS ADJUVANTS | AKZO NOBEL NV (NL) | 2010-11-17 | — | — | EP | claimed |
| US-20100204047-A1 | Alkoxylated asymmetric alkylamine surfactants as adjuvants | AKZO NOBEL N.V. (NL) | 2010-08-12 | — | — | US | claimed |
| EP-2161992-A1 | ALKOXYLATED ASYMMETRIC ALKYLAMINE SURFACTANTS AS ADJUVANTS | Akzo Nobel N.V. (NL) | 2010-03-17 | — | — | EP | claimed |
| WO-2009004044-A1 | ALKOXYLATED ASYMMETRIC ALKYLAMINE SURFACTANTS AS ADJUVANTS | AKZO NOBEL N.V. (NL) | 2009-01-08 | — | — | WO | claimed |
| US-20210298299-A1 | HARMFUL ORGANISM CONTROL COMPOSITION AND METHOD FOR USING THE SAME | NIHON NOHYAKU CO., LTD. (JP) | 2021-09-30 | — | — | US | disclosed |
| EP-3878282-A1 | PEST CONTROL AGENT COMPOSITION AND METHOD FOR USING SAME | Nihon Nohyaku Co., Ltd. (JP) | 2021-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210298299-A1 | HARMFUL ORGANISM CONTROL COMPOSITION AND METHOD FOR USING THE SAME | C1S, ATL3, C5 | PPARG 4015/4885PPARA 4127/4885SMN1; SMN2 2819/4885 |
| US-20100204047-A1 | Alkoxylated asymmetric alkylamine surfactants as adjuvants | ALK, CHRM2, CHRM1 | PPARG 323/4885PPARA 168/4885SMN1; SMN2 4105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.